Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

In a bombshell announcement made last week, the Food and Drug Administration (FDA) said it will ban the use of FD&C Red No. 3 ...

The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary supplements and ingested medicines, as reported on Wednesday.

The FDA approved trastuzumab deruxtecan for adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast ...

Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Northwell Health partnered with Stacker to explore how a new Pap smear alternative may help prevent deaths from cervical ...

The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer.The new indication applies to use of ...

Healthcare experts lauded the announcement by Finance Minister Nirmala Sitharaman to setting up daycare cancer centres, ...